Skip to main content

Table 5 Chi-square Hardy-Weinberg equilibrium tests for SNP data acquired by DNA microarray technology.

From: A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs

 

Cambodia

Tanzania

 

1st wash

2nd wash

1st wash

2nd wash

SNP

χ 2

P

χ 2

P

χ 2

P

χ 2

P

CYP2A6*2

23.00

< 0.01

7.29

< 0.01

23.57

< 0.01

34.02

< 0.01

CYP2B6*5

N.A.

 

N.A.

 

54.39

< 0.01

32.76

< 0.01

CYP2B6*6

N.A.

 

N.A.

 

16.90

< 0.01

17.41

< 0.01

CYP2C8*3

0.01

0.92

N.A.

 

8.22

< 0.01

39.35

< 0.01

CYP2C9*3

0.01

0.92

N.A.

 

22.08

< 0.01

11.13

< 0.01

CYP2C9*5

0.01

0.92

N.A.

 

14.69

< 0.01

14.30

< 0.01

CYP2C19*3

N.A.

 

N.A.

 

18.22

< 0.01

9.98

< 0.01

CYP2D6*4

0.01

0.92

N.A.

 

20.87

< 0.01

18.55

< 0.01

CYP2D6*10 (100C>T)

24.00

< 0.01

7.39

< 0.01

31.00

< 0.01

27.00

< 0.01

CYP2D6*10 (4180G>C)

13.67

< 0.01

N.A.

 

11.94

< 0.01

38.00

< 0.01

CYP2D6*17 (1023C>T)

11.90

< 0.01

7.00

< 0.01

0.45

0.5

35.34

< 0.01

CYP2D6*17 (2850C>T)

7.35

< 0.01

10.00

< 0.01

37.66

< 0.01

30.03

< 0.01

CYP3A4*1B

N.A.

 

N.A.

 

N.A.

 

24.00

< 0.01

CYP3A5*3

1.98

0.16

6.39

0.01

13.36

< 0.01

18.74

< 0.01

N.A.T2*5

8.41

< 0.01

3.32

0.07

13.83

< 0.01

13.70

< 0.01

N.A.T2*6

N.A.

 

N.A.

 

33.29

< 0.01

12.04

< 0.01

N.A.T2*7

9.97

< 0.01

8.63

< 0.01

30.21

< 0.01

24.82

< 0.01

N.A.T2*14

N.A.

 

N.A.

 

32.08

< 0.01

19.30

< 0.01

  1. χ2 indicates the result from the Hardy-Weinberg equilibrium test, P the one-tailed P-value, and N.A. that Chi-square could not be calculated because the allele frequency was either 0% or 100%.